Literature DB >> 15208579

Status of immunotherapy: current and future.

Thomas B Casale.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15208579     DOI： 10.1016/j.jaci.2004.04.017

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  3 in total

1.  Consensus Guidelines on Practical Issues of Immunotherapy-Canadian Society of Allergy and Clinical Immunology (CSACI).

Authors:  Eric Leith; Tom Bowen; Joe Butchey; David Fischer; Harold Kim; Bill Moote; Peter Small; Don Stark; Susan Waserman
Journal:  Allergy Asthma Clin Immunol       Date:  2006-06-15       Impact factor: 3.406

2.  Cytotoxic T lymphocyte antigen 4-immunoglobulin G is a potent adjuvant for experimental allergen immunotherapy.

Authors:  H Maazi; S Shirinbak; L E den Boef; F Fallarino; C Volpi; M C Nawijn; A J M van Oosterhout
Journal:  Clin Exp Immunol       Date:  2013-04       Impact factor: 4.330

Review 3.  6. Asthma: Factors underlying inception, exacerbation, and disease progression.

Authors:  Robert F Lemanske; William W Busse
Journal:  J Allergy Clin Immunol       Date:  2006-02       Impact factor: 10.793
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.